BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY
Omonjonov.S – 2
nd
year student
The Tashkent Pharmaceutical Institute
Language department
Supervisor:senior teacher Taryanikova M.A.
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular
and biomolecular processes to develop technologies and products that help improve our lives and
the health of our planet. We have used the biological processes of microorganisms for more than
6,000 years to enhance the agricultural production, to bake bread, brew alcoholic beverages, and
breed food crops or domestic animals. Through early biotechnology, the earliest farmers selected
and bred the best suited crops, having the highest yields, to produce enough food to support a
growing population. Modern biotechnology provides breakthrough products and technologies to
combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less
and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes.
Currently, there are more than 250 biotechnology health care products and vaccines available to
patients, many for previously untreatable diseases.
Biotechnology has also led to the development of antibiotics. In 1928, Alexander Fleming
discovered the mold Penicillium. His work led to the purification of the antibiotic by Howard
Florey, Ernst Boris Chain and Norman Heatley, penicillin. In 1940, penicillin became available for
medicinal use to treat bacterial infections in humans. The field of modern biotechnology is
generally thought of as having been born in 1971 when Paul Berg’s (Stanford) experiments in gene
splicing had early success. The commercial viability of a biotechnology industry was significantly
expanded on June 16, 1980, when the United States Supreme Court ruled that a genetically
modified microorganism could be patented in the case of Diamond V. Chakrabarty.
Biotechnology is being increasingly used in Drug production where biotechnical methods are now
used to produce many proteins for pharmaceutical and other specialized purposes. A harmless strain
of Escherichia coli bacteria, given a copy of the gene for human insulin, can make insulin. As these
genetically modified (GM) bacterial cells age, they produce human insulin, which can be purified
and used to treat diabetes in humans. Microorganisms can also be modified to produce digestive
enzymes. In the future, these microorganisms could be colonized in the intestinal tract of persons
with digestive enzyme insufficiencies. Products of modern biotechnology include artificial blood
vessels from collagen tubes coated with a layer of the anticoagulant heparin.
Following the phenomenal success of its information technology industry, India is fast emerging as
an important player in the biotechnology sector in the Asia–Pacific Region. But in Uzbekistan
biotechnology growth very slowly. To develop this branch we should attract the investments, open
new technological science centers and supply their with materials.
Do'stlaringiz bilan baham: